Syncona Investment Management Limited highlights progress translating frontier science into therapeutic reality at Capital Markets Day

AI Briefing

• – Syncona Investment Management Limited showcases its company-creation model as a key factor in translating frontier science into therapeutic reality.
• – The company highlights its approach to building ambitious, scalable and commercially attractive biotechnology companies.
• – This approach enables the development of breakthrough medicines.